Pathogen data in ChEMBL
The ChEMBL-og
SEPTEMBER 1, 2021
CO-ADD is an open-access, not-for-profit initiative whereby compounds provided by researchers and industry scientists are screened against a clinically relevant panel of bacteria and fungi. Since CO-ADD may re-screen hits against resistant bacterial strains or in cytotoxicity assays, more comprehensive data is available for some compounds.
52 
Let's personalize your content